- Filed
- Dec 19, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 1.35M sh |
| Shares Diluted restated | Q2 2025 · Jun 30, 2024 | 164.55K sh |
| Capex | Q2 2025 · Jun 30, 2025 | $40K |
| Capex | Q2 2025 · Jun 30, 2024 | $12.82K |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | −$3.4M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | $4.45M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $32.37M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $35.19M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $140.63M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $131.31M |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $26.61M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $11.76M |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $27.89M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $14.68M |
| Current Assets | Q2 2025 · Jun 30, 2025 | $75.83M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $117.8M |
| Total Assets | Q2 2025 · Jun 30, 2025 | $180.54M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $142.95M |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | $6.73 |
| Eps Diluted restated | Q2 2025 · Jun 30, 2024 | $8.34 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | $7.39 |
| Eps Basic restated | Q2 2025 · Jun 30, 2024 | $9.38 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $953.33K |
| Sga Expense restated | Q2 2025 · Jun 30, 2024 | $2.39M |
| Rd Expense | Q2 2025 · Jun 30, 2025 | $15.2K |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $35.62K |
| Net Income | Q2 2025 · Jun 30, 2025 | $9.49M |
| Net Income | Q2 2025 · Jun 30, 2024 | $1.11M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $3.26M |
| Operating Income restated | Q2 2025 · Jun 30, 2024 | $2.32M |
| Gross Profit | Q2 2025 · Jun 30, 2025 | $4.23M |
| Gross Profit restated | Q2 2025 · Jun 30, 2024 | $4.77M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $16.3M |
| Cost Of Revenue restated | Q2 2025 · Jun 30, 2024 | $16.72M |